Literature DB >> 20191297

Coexpression and nuclear colocalization of metastasis-promoting protein S100A4 and p53 without mutual regulation in colorectal carcinoma.

Gisle Berge1, Daniela Elena Costea, Marianne Berg, Heidi Rasmussen, Ida Grotterød, Ragnhild A Lothe, Gunhild M Mælandsmo, Kjersti Flatmark.   

Abstract

Nuclear localization of the metastasis-associated protein S100A4 has been shown to correlate with advanced disease stage in primary colorectal carcinomas (CRC), but nuclear function and its relevance for the metastatic capacity of tumor cells is still unclear. Among several nuclear interacting protein partners suggested for S100A4, the tumor suppressor protein p53 has attracted particular interest, and previous studies suggest direct and indirect modes of interaction between the two proteins. The present study was undertaken to assess coexpression and potential interaction in CRC. TP53 mutational status and S100A4 expression were investigated in a selected series of primary CRC specimens (n = 40) and cell lines (n = 17) using DNA sequencing, western blot, and double immunostaining. Additionally, S100A4 and p53 were experimentally up- and down-regulated in vitro to assess reciprocal effects. For the first time, S100A4 and p53 coexpression was demonstrated in individual CRC cells, with nuclear colocalization as a particularly interesting feature. In contrast to previous studies, no correlation was observed between TP53 mutational status and S100A4 expression, and no evidence was obtained to support reciprocal regulation between the two molecules in the HCT116 isogenic cell line model. In conclusion, S100A4 and p53 were shown to be colocalized in individual nuclei of CRC cells, and it might be speculated whether the proteins interact in this subcellular compartment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20191297     DOI: 10.1007/s00726-010-0514-6

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  4 in total

1.  Enrichment of nuclear S100A4 during G2/M in colorectal cancer cells: possible association with cyclin B1 and centrosomes.

Authors:  Eivind Valen Egeland; Kjetil Boye; Solveig J Pettersen; Mads H Haugen; Tove Øyjord; Lene Malerød; Kjersti Flatmark; Gunhild M Mælandsmo
Journal:  Clin Exp Metastasis       Date:  2015-09-09       Impact factor: 5.150

2.  Activated p53 in the anti-apoptotic milieu of tuberous sclerosis gene mutation induced diseases leads to cell death if thioredoxin reductase is inhibited.

Authors:  ElHusseiny M M Abdelwahab; Judit Bovari-Biri; Gabor Smuk; Janos Fillinger; Donald McPhail; Vera P Krymskaya; Judit E Pongracz
Journal:  Apoptosis       Date:  2021-04-16       Impact factor: 4.677

3.  S100 proteins as diagnostic and prognostic markers in colorectal and hepatocellular carcinoma.

Authors:  Claudia Maletzki; Peggy Bodammer; Anne Breitrück; Claus Kerkhoff
Journal:  Hepat Mon       Date:  2012-10-12       Impact factor: 0.660

Review 4.  S100 Proteins in Acute Myeloid Leukemia.

Authors:  Annette K Brenner; Øystein Bruserud
Journal:  Neoplasia       Date:  2018-10-23       Impact factor: 5.715

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.